Bladder cancer

L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Approaches to clinical complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer: Possibilities and limitations

HW Lee, WA Kwon, LNT Nguyen, DTT Phan, HK Seo - Cancers, 2023 - mdpi.com
Simple Summary Neoadjuvant chemotherapy followed by radical cystectomy is the
recommended standard of care for muscle-invasive bladder cancer patients who are eligible …

Bladder-sparing treatment with radical dose radiotherapy is an effective alternative to radical cystectomy in patients with clinically node-positive nonmetastatic bladder …

M Swinton, NBG Mariam, JL Tan… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Bladder-sparing trimodal therapy (TMT) is an alternative to radical cystectomy
(RC) according to international guidelines. However, there are limited data to guide …

Mtx-211 inhibits Gsh synthesis through Keap1/Nrf2/Gclm axis and exerts antitumor effects in bladder cancer

B Hu, R Chen, M Jiang, S Xiong, A Xie, X Liu… - International Journal of …, 2023 - mdpi.com
Globally, bladder cancer (BLCA) is still the leading cause of death in patients with tumors.
The function and underlying mechanism of MTX-211, an EFGR and PI3K kinase inhibitor …

Targeted quantitative metabolomics with a linear mixed-effect model for analysis of urinary nucleosides and deoxynucleosides from bladder cancer patients before …

M Artymowicz, W Struck-Lewicka, P Wiczling… - Analytical and …, 2023 - Springer
In the present study, we developed and validated a fast, simple, and sensitive quantitative
method for the simultaneous determination of eleven nucleosides and deoxynucleosides …

Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity

S Tabaei, MR Haghshenas, A Ariafar, K Gilany… - Clinical proteomics, 2023 - Springer
Background Non-muscle-invasive bladder cancer (NMIBC) has a high recurrence rate and
muscle-invasive bladder cancer (MIBC) has unfavorable outcomes in urothelial bladder …

Metabolomic signatures of treatment response in bladder cancer

T Vieira de Sousa, P Guedes de Pinho… - International Journal of …, 2023 - mdpi.com
Bladder cancer (BC) stands as one of the most prevalent urological malignancies, with over
500 thousand newly diagnosed cases annually. Treatment decisions in BC depend on …

Insights into vitamin A in bladder cancer, lack of attention to gut microbiota?

P Luo, L Zheng, J Zou, T Chen, J Zou, W Li… - Frontiers in …, 2023 - frontiersin.org
Vitamin A has long been associated with bladder cancer, and many exogenous vitamin A
supplements, vitamin A derivatives, and synthetic drugs have been investigated over the …

[HTML][HTML] The bladder microbiome of nmibc and mibc patients revealed by 2brad-m

JX Sun, QD Xia, XY Zhong, Z Liu… - Frontiers in Cellular and …, 2023 - frontiersin.org
Background Bladder cancer (BCa) is the most common malignancy of the urinary tract which
can be divided into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive …

[HTML][HTML] Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis

MI Khan, H Qureshi, S Akhtar, SJ Bae… - Frontiers in Psychiatry, 2023 - frontiersin.org
Introduction By conducting a systematic review and meta-analysis, we investigated the
prevalence of neuropsychiatric (NP) symptoms among systemic lupus erythematosus (SLE) …